Abstract
The UAE implemented swift and proactive mitigation measures to combat the COVID-19 pandemic. While there are currently five primary approved vaccines in the UAE, inactivated vaccine BBIBP-CorV (Sinopharm), which has a 78% effectiveness in preventing hospitalization due to COVID-19 infections, 1 and mRNA vaccine BNT162b2 (Pfizer-BioNTech), with an effectiveness at 93% in preventing hospitalization due to COVID-19 infections, 2 are most commonly administered. Due to the successful early COVID-19 vaccination rollout, ~91.6% of the population has been vaccinated, which is mainly attributed to a model governance system, logistical capabilities, accessibility and delivery, digital infrastructure and vaccine manufacturing facility. 3
Funding Information
  • Ministry of Health
  • Khalifa University’s CPRA (2020-004)